Surgical Ablation in Congenital Heart Disease: Advances in Techniques and Clinical Outcomes
Manouk H. C. Linderhof1,#, Hoang H. Nguyen1,2,#, Annemien E. van den Bosch1, Mathijs S. van Schie1, Vehpi Yildirim1, Yannick J. H. J. Taverne3, Natasja M. S. de Groot1,*
Congenital Heart Disease, Vol.19, No.6, pp. 577-592, 2024, DOI:10.32604/chd.2025.062129
- 27 January 2025
Abstract Surgical ablation (SA) has become an essential rhythm-control strategy for managing tachyarrhythmias in patients with congenital heart disease. Atrial tachyarrhythmias, such as atrial flutter and atrial fibrillation, are prevalent in congenital heart disease, affecting up to 50% of patients, and pose significant risks, including increased morbidity and mortality. Ventricular tachyarrhythmias, though less common, can lead to sudden cardiac death, particularly in conditions like Tetralogy of Fallot. Prior studies suggested that SA for tachyarrhythmias in patients with congenital heart disease offers significant benefits, including superior long-term rhythm control compared to catheter ablation (CA). Atrial tachyarrhythmia burden… More >